Service Insight: Submission development and market access
June 28, 2011Sales and Marketing Service Insight
SERVICE INSIGHT A successful health technology assessment is critical for market access in the UK. However, submissions that don’t follow …
Pfizer sells Irish manufacturing facility to BioMarin
June 27, 2011Manufacturing and Production BioMarin, Ireland, Pfizer, pharma manufacturing news
Pfizer is selling its Irish manufacturing facility in Shanbally, Cork, to US biopharmaceutical company BioMarin for $48.5 million, creating up …
Activaero appoints Christian Pangratz
June 27, 2011Sales and Marketing appointment, sales and marketing
Activaero GmbH has appointed Christian Pangratz as chief business officer, with a brief to lead its business development, marketing and …
CHMP backs Boehringer-Lilly diabetes drug Trajenta
June 27, 2011Sales and Marketing Tradjenta, Trajenta, diabetes
Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been recommended for European approval. It was given …
Bury the NHS reform bill, says BMJ
June 27, 2011Health and Social Care Bill, NHS reforms
The influential British Medical Journal has called on the government to abandon its healthcare reform bill, which it says has …
Beyond technology: how pharma marketing will be transformed…..
June 27, 2011Medical Communications, Sales and Marketing digital marketing, pharma marketing
I speak about social media and pharma company communications all the time. I find myself talking about it not just …
Novo Nordisk invests €134m in Danish facility
June 24, 2011Manufacturing and Production Novo Nordisk, biologics, pharma manufacturing news
Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …
Chamberlain moves under CCC umbrella
June 24, 2011Medical Communications medical communications, medical communications agency, medical communications news
Health PR specialist Chamberlain Communications Group is to come under the umbrella of Chandler Chicco Companies (CCC) as a prelude …
Pfizer to retain 350 jobs at Sandwich
June 24, 2011Research and Development Pfizer, Sandwich, pharma jobs, recruitment
Pfizer has made the surprise decision to retain 350 jobs at its research and development site in Sandwich, Kent, providing …
Roche and Evotec to collaborate on cancer biomarkers
June 24, 2011Research and Development Evotec, Roche, biomarkers
Roche and Evotec are to collaborate to find biomarkers for Roche oncology drugs under development. Roche has been one of …
Roche launches R&D Institute in France
June 24, 2011Research and Development Roche, translational research
Roche has launched a new R&D Institute in France, furthering its links with academic centres in the country. The Institute, …
Succinct Communications boosts team
June 24, 2011Medical Communications appointment, medical communications
Succinct Healthcare Communications has strengthened its team with four new appointments.Andrea Scales joins Amersham, UK-based agency as editorial assistant, James …
Service Insight: Creative consumer communications and pharma
June 24, 2011Medical Communications Service Insight, advertising, creativity, fmcg
SERVICE INSIGHTI arrived in healthcare communications having spent 12 years as a creative PR consultant within the FMCG and technology …
Menarini pilots UK gout awareness campaign
June 23, 2011Medical Communications Menarini, disease awareness, disease awareness campaigns
A. Menarini Pharma UK has piloted a new gout awareness campaign in the North East and is preparing to give …
Service Insight: Keeping up with changes in the NHS
June 23, 2011Sales and Marketing Service Insight
SERVICE INSIGHT
John Burt takes on leadership of PolyTherics
June 23, 2011Research and Development appointment, research and development
PolyTherics has promoted John Burt from chief business officer to chief executive.Prior to joining PolyTherics, which applies precision chemistry to …
Merck scraps MS pill cladribine
June 23, 2011Research and Development, Sales and Marketing Cladribine, Merck KGaA, Movectro, multiple sclerosis
Merck KGaA has pulled all pending applications for its multiple sclerosis pill Movectro and will withdraw it from the markets …
Sanofi to boost early-stage research with ‘real world’ evidence
June 23, 2011Research and Development Sanofi, patient data, pharma research
Sanofi is aiming to maximise its R&D investment by including ‘real world’ evidence in its product development strategy. The company …
AstraZeneca sells off dental business for $1.8bn
June 23, 2011Sales and Marketing AstraZeneca, strategy
AstraZeneca is to sell its dental products firm Astra Tech to DENTSPLY for $1.8 billion. Astra Tech comprises two business …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
